advertisement
3.8 Pharmacology (87)
Showing records 1 to 25
Display all abstracts in classification 3.8 Pharmacology
Search within classification 3.8 Pharmacology70838 The arguments for and against cannabinoids application in glaucomatous retinopathy
Panahi Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 86: 620-627
69964 Structural features of subtype-selective EP receptor modulators
Markovič T
Drug Discovery Today 2017; 22: 57-71
70376 Translational Pharmacology in Glaucoma Neuroprotection
Levin LA
Handb Exp Pharmacol 2017; 242: 209-230
70157 TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Ishikawa M
Neuropharmacology 2016; 111: 142-159
70158 The protection of rat retinal ganglion cells from ischemia/reperfusion injury by the inhibitory peptide of mitochondrial μ-calpain
Ozaki T
Biochemical and Biophysical Research Communications 2016; 478: 1700-1705
70073 Puerarin Attenuates N-Methyl-D-aspartic Acid-induced Apoptosis and Retinal Ganglion Cell Damage Through the JNK/p38 MAPK Pathway
Lv B
Journal of Glaucoma 2016; 25: e792-e801
70632 Glaucoma: Hot topics in Pharmacology
Balendra SI
Current Pharmaceutical Design 2017; 23: 596-607
70344 Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma
Baumane K
Current Eye Research 2016; 0: 1-4
70138 Nitric oxide and tumour necrosis factor alpha in the process of pseudoexfoliation glaucoma
Sarenac Vulovic TS
International Journal of Ophthalmology 2016; 9: 1138-1142
70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Lambuk L
Neurotoxicity research 2017; 31: 31-45
70434 Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
Dismuke WM
PLoS ONE 2016; 11: e0165326
70482 Glaucoma-Intraocular Pressure Reduction
Huang AS
Handb Exp Pharmacol 2017; 242: 181-207
70725 Therapeutic role of nitric oxide as emerging molecule
Kumar S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2017; 85: 182-201
70622 Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure
Miller S
Investigative Ophthalmology and Visual Science 2016; 57: 6419-6426
70354 Principles of Ocular Pharmacology
Park Y
Handb Exp Pharmacol 2017; 242: 3-30
70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Araújo DS
Experimental Eye Research 2016; 154: 116-125
70115 Ocular Purine Receptors as Drug Targets in the Eye
Jacobson KA
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 534-547
70839 New furoxan derivatives for the treatment of ocular hypertension
Blangetti M
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483
70354 Principles of Ocular Pharmacology
Ellis D
Handb Exp Pharmacol 2017; 242: 3-30
70839 New furoxan derivatives for the treatment of ocular hypertension
Rolando B
Bioorganic and Medicinal Chemistry Letters 2017; 27: 479-483
70434 Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone
Klingeborn M
PLoS ONE 2016; 11: e0165326
70482 Glaucoma-Intraocular Pressure Reduction
Minasyan L
Handb Exp Pharmacol 2017; 242: 181-207
70601 Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Miya-Coreixas VS
Experimental Eye Research 2016; 154: 116-125
70102 Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina
Jafri AJ
Neurotoxicity research 2017; 31: 31-45
69964 Structural features of subtype-selective EP receptor modulators
Jakopin Ž
Drug Discovery Today 2017; 22: 57-71